|
|
|
|
pmid:
|
Shalhoub V et al. |
Osteoprotegerin and osteoprotegerin ligand effects on osteoclast formation from human peripheral blood mononuclear cell precursors. |
1999 |
J. Cell. Biochem. |
pmid:10022507
|
Hsu H et al. |
Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. |
1999 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:10097072
|
Nagai M and Sato N |
Reciprocal gene expression of osteoclastogenesis inhibitory factor and osteoclast differentiation factor regulates osteoclast formation. |
1999 |
Biochem. Biophys. Res. Commun. |
pmid:10208850
|
Burgess TL et al. |
The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts. |
1999 |
J. Cell Biol. |
pmid:10225954
|
Kong YY et al. |
Osteoprotegerin ligand: a common link between osteoclastogenesis, lymph node formation and lymphocyte development. |
1999 |
Immunol. Cell Biol. |
pmid:10234557
|
Yano K et al. |
Immunological characterization of circulating osteoprotegerin/osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis. |
1999 |
J. Bone Miner. Res. |
pmid:10234572
|
Zhang XD et al. |
Relation of TNF-related apoptosis-inducing ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma. |
1999 |
Cancer Res. |
pmid:10364001
|
Spelsberg TC et al. |
The actions and interactions of sex steroids and growth factors/cytokines on the skeleton. |
1999 |
Mol. Endocrinol. |
pmid:10379881
|
Yasuda H et al. |
A novel molecular mechanism modulating osteoclast differentiation and function. |
1999 |
Bone |
pmid:10423033
|
Roodman GD |
Cell biology of the osteoclast. |
1999 |
Exp. Hematol. |
pmid:10428500
|
Lee SK and Lorenzo JA |
Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation. |
1999 |
Endocrinology |
pmid:10433211
|
Ito H et al. |
Hedgehog signaling molecules in bone marrow cells at the initial stage of fracture repair. |
1999 |
Biochem. Biophys. Res. Commun. |
pmid:10462495
|
Hofbauer LC et al. |
Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells. |
1999 |
Endocrinology |
pmid:10465311
|
Morony S et al. |
A chimeric form of osteoprotegerin inhibits hypercalcemia and bone resorption induced by IL-1beta, TNF-alpha, PTH, PTHrP, and 1, 25(OH)2D3. |
1999 |
J. Bone Miner. Res. |
pmid:10469275
|
Sakata M et al. |
Expression of osteoprotegerin (osteoclastogenesis inhibitory factor) in cultures of human dental mesenchymal cells and epithelial cells. |
1999 |
J. Bone Miner. Res. |
pmid:10469276
|
Lazner F et al. |
Osteopetrosis and osteoporosis: two sides of the same coin. |
1999 |
Hum. Mol. Genet. |
pmid:10469835
|
Hofbauer LC |
Osteoprotegerin ligand and osteoprotegerin: novel implications for osteoclast biology and bone metabolism. |
1999 |
Eur. J. Endocrinol. |
pmid:10474114
|
Wickelgren I |
Mining the genome for drugs. |
1999 |
Science |
pmid:10475849
|
Hofbauer LC et al. |
Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis. |
1999 |
Endocrinology |
pmid:10499489
|